Importantly, we found that in HCC cell lines as well as c‐Myc mouse HCC, Dasatinib treatment induced up regulation of activated/phosphorylated (p)‐focal adhesion kinase(FAK). This evidence concerns the gene MYC and hepatocellular carcinoma.